Literature DB >> 18722802

Dopamine beta-hydroxylase -1021C>T association and Parkinson's disease.

Owen A Ross1, Michael G Heckman, Alexandra I Soto, Nancy N Diehl, Kristoffer Haugarvoll, Carles Vilariño-Güell, Jan O Aasly, Sigrid Sando, J Mark Gibson, Timothy Lynch, Anna Krygowska-Wajs, Grzegorz Opala, Maria Barcikowska, Krzysztof Czyzewski, Ryan J Uitti, Zbigniew K Wszolek, Matthew J Farrer.   

Abstract

A single nucleotide polymorphism in the promoter region of the dopamine beta-hydroxylase gene (DBH -1021C>T; rs1611115) is reported to regulate plasma enzyme activity levels. This variant has also been the focus of two large association studies in Parkinson's disease yielding conflicting results. We examined this association in four Caucasian patient-control series (n=2696). A modest protective association was observed in the Norwegian series (OR=0.81, p=0.03; n=1676), however, the effect was in the opposite direction in the Polish series (OR=2.01, p=0.01; n=224). No association was observed for DBH -1021C>T with disease susceptibility in the US and Irish series, or combining all four series (OR=0.91, p=0.16, n=2696). We observed a modest association between DBH -1021C>T and AAO in the combined series (p=0.01). Taken together, these findings indicate that DBH -1021C>T does not play a major role in the pathogenesis of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722802      PMCID: PMC2592561          DOI: 10.1016/j.parkreldis.2008.07.002

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  10 in total

1.  A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.

Authors:  Alessio Di Fonzo; Yah-Huei Wu-Chou; Chin-Song Lu; Marina van Doeselaar; Erik J Simons; Christan F Rohé; Hsiu-Chen Chang; Rou-Shayn Chen; Yi-Hsin Weng; Nicola Vanacore; Guido J Breedveld; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2006-04-22       Impact factor: 2.660

2.  Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

Authors:  Demetrius M Maraganore; Mariza de Andrade; Alexis Elbaz; Matthew J Farrer; John P Ioannidis; Rejko Krüger; Walter A Rocca; Nicole K Schneider; Timothy G Lesnick; Sarah J Lincoln; Mary M Hulihan; Jan O Aasly; Tetsuo Ashizawa; Marie-Christine Chartier-Harlin; Harvey Checkoway; Carlo Ferrarese; Georgios Hadjigeorgiou; Nobutaka Hattori; Hideshi Kawakami; Jean-Charles Lambert; Timothy Lynch; George D Mellick; Spiridon Papapetropoulos; Abbas Parsian; Aldo Quattrone; Olaf Riess; Eng-King Tan; Christine Van Broeckhoven
Journal:  JAMA       Date:  2006-08-09       Impact factor: 56.272

3.  Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.

Authors:  Ikuko Mizuta; Wataru Satake; Yuko Nakabayashi; Chiyomi Ito; Satoko Suzuki; Yoshio Momose; Yoshitaka Nagai; Akira Oka; Hidetoshi Inoko; Jiro Fukae; Yuko Saito; Motoji Sawabe; Shigeo Murayama; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Tatsushi Toda
Journal:  Hum Mol Genet       Date:  2006-02-24       Impact factor: 6.150

4.  Multiple regions of alpha-synuclein are associated with Parkinson's disease.

Authors:  Jakob C Mueller; Julia Fuchs; Anne Hofer; Alexander Zimprich; Peter Lichtner; Thomas Illig; Daniela Berg; Ullrich Wüllner; Thomas Meitinger; Thomas Gasser
Journal:  Ann Neurol       Date:  2005-04       Impact factor: 10.422

5.  A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus.

Authors:  C P Zabetian; G M Anderson; S G Buxbaum; R C Elston; H Ichinose; T Nagatsu; K S Kim; C H Kim; R T Malison; J Gelernter; J F Cubells
Journal:  Am J Hum Genet       Date:  2001-01-19       Impact factor: 11.025

6.  The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity.

Authors:  Cyrus P Zabetian; Sarah G Buxbaum; Robert C Elston; Michael D Köhnke; George M Anderson; Joel Gelernter; Joseph F Cubells
Journal:  Am J Hum Genet       Date:  2003-04-30       Impact factor: 11.025

7.  Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.

Authors:  Owen A Ross; Yih-Ru Wu; Mei-Ching Lee; Manabu Funayama; Meng-Ling Chen; Alexandra I Soto; Ignacio F Mata; Guey-Jen Lee-Chen; Chiung Mei Chen; Michelle Tang; Yi Zhao; Nobutaka Hattori; Matthew J Farrer; Eng-King Tan; Ruey-Meei Wu
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

Review 8.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01

9.  DBH -1021C-->T does not modify risk or age at onset in Parkinson's disease.

Authors:  Lani S Chun; Ali Samii; Carolyn M Hutter; Alida Griffith; John W Roberts; Berta C Leis; Anthony D Mosley; P Luke Wander; Karen L Edwards; Haydeh Payami; Cyrus P Zabetian
Journal:  Ann Neurol       Date:  2007-07       Impact factor: 10.422

10.  A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease.

Authors:  Daniel G Healy; Patrick M Abou-Sleiman; Tetsutaro Ozawa; Andrew J Lees; Kailash Bhatia; Kourosh R Ahmadi; Ullrich Wullner; Jose Berciano; J Carsten Moller; Christoph Kamm; Katrin Burk; Paolo Barone; Eduardo Tolosa; Niall Quinn; David B Goldstein; Nicholas W Wood; Paolo Barrone
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

  10 in total
  4 in total

1.  Association of the rs1611115 polymorphism in DBH gene with Parkinson's disease: a meta-analysis.

Authors:  Shan Kang; Mingxia Bi; Xixun Du; Qian Jiao; Hong Jiang
Journal:  Neurol Sci       Date:  2018-09-05       Impact factor: 3.307

2.  Structural insight of dopamine β-hydroxylase, a drug target for complex traits, and functional significance of exonic single nucleotide polymorphisms.

Authors:  Abhijeet Kapoor; Manish Shandilya; Suman Kundu
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

3.  Association of Dopamine Beta-Hydroxylase (DBH) Polymorphisms with Susceptibility to Parkinson's Disease.

Authors:  Peng Shao; Yun-Xia Yu; Jing-Xi Bao
Journal:  Med Sci Monit       Date:  2016-05-13

4.  Genomic, transcriptomic, and metabolomic profiles of hiPSC-derived dopamine neurons from clinically discordant brothers with identical PRKN deletions.

Authors:  Holly N Cukier; Hyunjin Kim; Anthony J Griswold; Simona G Codreanu; Lisa M Prince; Stacy D Sherrod; John A McLean; Derek M Dykxhoorn; Kevin C Ess; Peter Hedera; Aaron B Bowman; M Diana Neely
Journal:  NPJ Parkinsons Dis       Date:  2022-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.